NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

護理點(POC)葡萄糖測試市場規模調查:按產品,購買方式,最終用戶2025年全球預測-COVID-19的累積影響

Point-of-Care Glucose Testing Market Research Report by Product, by Mode of Purchase, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 995356
出版日期 內容資訊 英文 190 Pages
商品交期: 最快1-2個工作天內
價格
護理點(POC)葡萄糖測試市場規模調查:按產品,購買方式,最終用戶2025年全球預測-COVID-19的累積影響 Point-of-Care Glucose Testing Market Research Report by Product, by Mode of Purchase, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 190 Pages
簡介

全球護理點(POC)葡萄糖測試市場預計將從2020年的5,436,840,000美元增長到2025年底的7,455,480,000美元。

預計COVID-19將在預測期內對行業增長產生長期影響,因為這是無與倫比的全球公共衛生突發事件,幾乎影響了每個行業。我們正在進行的研究擴大了研究框架,以確保它包括潛在的COVID-19問題和潛在的未來路徑。該調查提供了對COVID-19的見解,並考慮了消費者行為和需求,購買模式,供應鏈改路,當前市場勢力動態以及政府的主要干預措施的變化。更新後的調查提供了見解,分析,估計和預測,其中考慮了COVID-19對市場的影響。

本報告調查了護理點(POC)葡萄糖測試市場,並分析了按產品,按購買方式,按最終用戶和按地區劃分的市場概況,市場增長和障礙,並提供了有關趨勢和預測的全面信息, COVID-19的累積影響,競爭條件,主要公司的形象,市場機會等等。

目錄

第1章簡介

  • 調查目的
  • 市場細分和覆蓋範圍
  • 調查目標年度
  • 貨幣和價格
  • 語言
  • 限制
  • 利益相關者

第2章調查方法

  • 調查過程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:測量設備
    • 集合:數據源
    • 分析:數據解釋
    • 公式:數據驗證
    • 已發佈:調查報告
    • 重複:報告更新
  • 進行調查
    • 開始:調查過程
    • 計劃:創建調查計劃
    • 執行:進行調查
    • 驗證:發現和分析
    • 出版物:調查報告
  • 調查結果

第3章執行摘要

  • 市場前景
  • 按購買方式顯示的展望
  • 最終用戶的展望
  • 產品前景
  • 區域展望
  • 競爭對手展望

第4章市場概述

  • COVID-19的累積效果

第5章市場洞察

  • 市場動態
    • 促進因素
    • 抑制因素
    • 市場機會
    • 挑戰
  • 波特五力分析
    • 新進入者的威脅
    • 替代威脅
    • 客戶的議價能力
    • 供應商的談判能力
    • 行業競爭

第6章按產品分列的全球護理點(POC)葡萄糖測試市場

  • Accu Check Aviva Meter
  • Accu-ChekInformII
  • 拜耳輪廓血糖監測系統
  • 自由式燈光
  • i-STAT
  • 一鍵式Verio Flex
  • StatStrip
  • True Metrix

第7章,按購買方式劃分的全球護理點(POC)葡萄糖測試市場

  • OTC測試產品
  • 處方測試產品

第8章最終用戶的全球護理點(POC)葡萄糖測試市場

  • 家庭護理設置
  • 醫院和重症監護中心
  • 門診和門診診所

第9章美洲概念驗證(POC)葡萄糖測試市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太護理點(POC)葡萄糖測試市場

  • 澳大利亞
  • 中國
  • 印度
  • 印度尼西亞
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第11章歐洲/中東/非洲護理點(POC)葡萄糖測試市場

  • 法國
  • 德國
  • 意大利
  • 荷蘭
  • 卡塔爾
  • 俄羅斯
  • 沙特阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合酋長國
  • 英國

第12章競爭情況

  • FPNV定位矩陣
    • 象限
    • 經營策略
    • 產品滿意度
  • 市場排名分析
  • 市場份額分析
  • 競爭性SWOT分析
  • 競爭情況
    • 併購
    • 協議,合作和夥伴關係
    • 推出和增強新產品
    • 投融資
    • 獎賞,表彰,擴張

第13章企業可用性概況

  • Abbott
  • Acon Laboratories, Inc.
  • Alere
  • Bayer AG/Ascensia Diabetes Care Holdings AG
  • EKF Diagnostics
  • F. Hoffmann-La Roche Ltd.
  • Nipro
  • Nova Biomedical
  • Platinum Equity, LLC. (LifeScan, Inc.)
  • Prodigy Diabetes Care, LLC.
  • Trividia Health, Inc.

第14章附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-B9334AD6C463

The Global Point-of-Care Glucose Testing Market size was estimated at USD 5,436.84 Million in 2020 and expected to reach USD 5,818.43 Million in 2021, at a Compound Annual Growth Rate (CAGR) 7.35% to reach USD 8,323.97 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Point-of-Care Glucose Testing to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product , the Point-of-Care Glucose Testing Market was studied across Accu Check Aviva Meter, Accu-Chek Inform II, Bayer Contour Blood Glucose Monitoring System, Freestyle Lite, i-STAT, Onetouch Verio Flex, StatStrip, and True Metrix.

Based on Mode of Purchase, the Point-of-Care Glucose Testing Market was studied across OTC Testing Product and Prescription-based Testing Product.

Based on End User, the Point-of-Care Glucose Testing Market was studied across Home Care Settings, Hospitals & Critical Care Centers, and Outpatient & Ambulatory Care Facilities.

Based on Geography, the Point-of-Care Glucose Testing Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Point-of-Care Glucose Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Point-of-Care Glucose Testing Market, including Abbott Laboratories, Accubiotech Co. Ltd., ACON Laboratories, Inc., Becton, Dickinson, and Company, Bio-Rad Laboratories, bioLytical Laboratories Inc., Chembio Diagnostics, Inc, Danaher Corporation, EKF Diagnostics, F. Hoffmann-La Roche Ltd., Fluxergy, LifeScan, Inc. By Platinum Equity, LLC., Medtronic PLC, Nipro Corporation, Nova Biomedical Corporation, OraSure Technologies Inc., Prodigy Diabetes Care, LLC., Quidel Corporation, Sekisui Diagnostics, LLC, Siemens Healthineers AG, Sinocare, Trinity Biotech PLC, Trividia Health, Inc., and Zoetis Inc..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Point-of-Care Glucose Testing Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Point-of-Care Glucose Testing Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Point-of-Care Glucose Testing Market?
  • 4. What is the competitive strategic window for opportunities in the Global Point-of-Care Glucose Testing Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Point-of-Care Glucose Testing Market?
  • 6. What is the market share of the leading vendors in the Global Point-of-Care Glucose Testing Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Point-of-Care Glucose Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Mode of Purchase Outlook
  • 3.4. End User Outlook
  • 3.5. Product Outlook
  • 3.6. Geography Outlook
  • 3.7. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in the prevalence rate of diabetic patients
      • 5.1.1.2. Growing incorporation of data management programs in the monitoring of glucose
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of product development
    • 5.1.3. Opportunities
      • 5.1.3.1. Adoption of advanced technology with smartphone orientation, embedded vision-based solutions, and digital technologies for better testing
      • 5.1.3.2. Growing demand for home healthcare from developed and developing countries
    • 5.1.4. Challenges
      • 5.1.4.1. Potential interference and calibration issues in glucose meters
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Point-of-Care Glucose Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Accu Check Aviva Meter
  • 6.3. Accu-Chek Inform II
  • 6.4. Bayer Contour Blood Glucose Monitoring System
  • 6.5. Freestyle Lite
  • 6.6. i-STAT
  • 6.7. Onetouch Verio Flex
  • 6.8. StatStrip
  • 6.9. True Metrix

7. Point-of-Care Glucose Testing Market, by Mode of Purchase

  • 7.1. Introduction
  • 7.2. OTC Testing Product
  • 7.3. Prescription-based Testing Product

8. Point-of-Care Glucose Testing Market, by End User

  • 8.1. Introduction
  • 8.2. Home Care Settings
  • 8.3. Hospitals & Critical Care Centers
  • 8.4. Outpatient & Ambulatory Care Facilities

9. Americas Point-of-Care Glucose Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States
    • 9.6.1. California
    • 9.6.2. Florida
    • 9.6.3. Illinois
    • 9.6.4. New York
    • 9.6.5. Ohio
    • 9.6.6. Pennsylvania
    • 9.6.7. Texas

10. Asia-Pacific Point-of-Care Glucose Testing Market

  • 10.1. Introduction
  • 10.2. China
  • 10.3. India
  • 10.4. Indonesia
  • 10.5. Japan
  • 10.6. Malaysia
  • 10.7. Philippines
  • 10.8. South Korea
  • 10.9. Thailand

11. Europe, Middle East & Africa Point-of-Care Glucose Testing Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Quadrant
  • 12.4. Market Share Analysis, By Company
  • 12.5. Competitive Scenario
    • 12.5.1. Merger & Acquisition
    • 12.5.2. Agreement, Collaboration, & Partnership
    • 12.5.3. New Product Launch & Enhancement
    • 12.5.4. Investment & Funding
    • 12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. Abbott Laboratories
  • 13.2. Accubiotech Co. Ltd.
  • 13.3. ACON Laboratories, Inc.
  • 13.4. Becton, Dickinson, and Company
  • 13.5. Bio-Rad Laboratories
  • 13.6. bioLytical Laboratories Inc.
  • 13.7. Chembio Diagnostics, Inc
  • 13.8. Danaher Corporation
  • 13.9. EKF Diagnostics
  • 13.10. F. Hoffmann-La Roche Ltd.
  • 13.11. Fluxergy
  • 13.12. LifeScan, Inc. By Platinum Equity, LLC.
  • 13.13. Medtronic PLC
  • 13.14. Nipro Corporation
  • 13.15. Nova Biomedical Corporation
  • 13.16. OraSure Technologies Inc.
  • 13.17. Prodigy Diabetes Care, LLC.
  • 13.18. Quidel Corporation
  • 13.19. Sekisui Diagnostics, LLC
  • 13.20. Siemens Healthineers AG
  • 13.21. Sinocare
  • 13.22. Trinity Biotech PLC
  • 13.23. Trividia Health, Inc.
  • 13.24. Zoetis Inc.

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
  • 14.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2020 (USD MILLION)
  • FIGURE 5. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: MARKET DYNAMICS
  • FIGURE 7. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 8. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2020 VS 2026 (%)
  • FIGURE 9. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2020 VS 2026 (USD MILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2026
  • FIGURE 11. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ACCU CHECK AVIVA METER, 2018-2026 (USD MILLION)
  • FIGURE 12. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ACCU CHECK AVIVA METER, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 13. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ACCU-CHEK INFORM II, 2018-2026 (USD MILLION)
  • FIGURE 14. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ACCU-CHEK INFORM II, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 15. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY BAYER CONTOUR BLOOD GLUCOSE MONITORING SYSTEM, 2018-2026 (USD MILLION)
  • FIGURE 16. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY BAYER CONTOUR BLOOD GLUCOSE MONITORING SYSTEM, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 17. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY FREESTYLE LITE, 2018-2026 (USD MILLION)
  • FIGURE 18. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY FREESTYLE LITE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 19. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY I-STAT, 2018-2026 (USD MILLION)
  • FIGURE 20. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY I-STAT, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 21. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONETOUCH VERIO FLEX, 2018-2026 (USD MILLION)
  • FIGURE 22. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONETOUCH VERIO FLEX, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 23. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY STATSTRIP, 2018-2026 (USD MILLION)
  • FIGURE 24. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY STATSTRIP, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 25. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TRUE METRIX, 2018-2026 (USD MILLION)
  • FIGURE 26. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TRUE METRIX, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 27. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2020 VS 2026 (%)
  • FIGURE 28. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2020 VS 2026 (USD MILLION)
  • FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2026
  • FIGURE 30. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OTC TESTING PRODUCT, 2018-2026 (USD MILLION)
  • FIGURE 31. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OTC TESTING PRODUCT, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 32. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRESCRIPTION-BASED TESTING PRODUCT, 2018-2026 (USD MILLION)
  • FIGURE 33. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRESCRIPTION-BASED TESTING PRODUCT, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 34. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2020 VS 2026 (%)
  • FIGURE 35. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
  • FIGURE 36. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2026
  • FIGURE 37. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE SETTINGS, 2018-2026 (USD MILLION)
  • FIGURE 38. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE SETTINGS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 39. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CRITICAL CARE CENTERS, 2018-2026 (USD MILLION)
  • FIGURE 40. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CRITICAL CARE CENTERS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 41. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OUTPATIENT & AMBULATORY CARE FACILITIES, 2018-2026 (USD MILLION)
  • FIGURE 42. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OUTPATIENT & AMBULATORY CARE FACILITIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 43. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 44. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 45. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 46. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 47. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 48. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 49. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 50. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 51. CALIFORNIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 52. FLORIDA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 53. ILLINOIS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 54. NEW YORK POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 55. OHIO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 56. PENNSYLVANIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 57. TEXAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 58. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 59. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 60. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 61. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 62. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 63. INDONESIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 64. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 65. MALAYSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 66. PHILIPPINES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 67. SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 68. THAILAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 69. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 70. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 71. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 72. FRANCE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 73. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 74. ITALY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 75. NETHERLANDS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 76. QATAR POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 77. RUSSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 78. SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 79. SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 80. SPAIN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 81. UNITED ARAB EMIRATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 82. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 83. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: FPNV POSITIONING MATRIX
  • FIGURE 84. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 85. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 86. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ACCU CHECK AVIVA METER, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ACCU-CHEK INFORM II, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY BAYER CONTOUR BLOOD GLUCOSE MONITORING SYSTEM, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY FREESTYLE LITE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY I-STAT, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONETOUCH VERIO FLEX, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY STATSTRIP, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TRUE METRIX, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OTC TESTING PRODUCT, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRESCRIPTION-BASED TESTING PRODUCT, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE SETTINGS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CRITICAL CARE CENTERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY OUTPATIENT & AMBULATORY CARE FACILITIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. AMERICAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. ARGENTINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. CALIFORNIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. CALIFORNIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. CALIFORNIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. FLORIDA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. FLORIDA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. FLORIDA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. ILLINOIS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. ILLINOIS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. ILLINOIS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. NEW YORK POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. NEW YORK POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. NEW YORK POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. OHIO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. OHIO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. OHIO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. PENNSYLVANIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. PENNSYLVANIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. PENNSYLVANIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. TEXAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. TEXAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. TEXAS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. INDONESIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. INDONESIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. INDONESIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. MALAYSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. MALAYSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. MALAYSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. PHILIPPINES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. PHILIPPINES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. PHILIPPINES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. THAILAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. THAILAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. THAILAND POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. FRANCE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. FRANCE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. FRANCE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. ITALY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. ITALY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. ITALY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. NETHERLANDS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. NETHERLANDS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. NETHERLANDS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 104. QATAR POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 105. QATAR POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 106. QATAR POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 107. RUSSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 108. RUSSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 109. RUSSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 110. SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 111. SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 112. SAUDI ARABIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 113. SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 114. SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 115. SOUTH AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 116. SPAIN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 117. SPAIN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 118. SPAIN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 119. UNITED ARAB EMIRATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 120. UNITED ARAB EMIRATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 121. UNITED ARAB EMIRATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 122. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 123. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 124. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 125. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: SCORES
  • TABLE 126. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: BUSINESS STRATEGY
  • TABLE 127. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: PRODUCT SATISFACTION
  • TABLE 128. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: RANKING
  • TABLE 129. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 130. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: SHARE, BY COMPANY, 2020
  • TABLE 131. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: MERGER & ACQUISITION
  • TABLE 132. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 133. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 134. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: INVESTMENT & FUNDING
  • TABLE 135. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 136. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: LICENSE & PRICING
  • TABLE 137. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: CONTACT DETAILS